Delivery Order SPE2DB20D3101-SPE2DB22FK1K5

Award Date 6/16/22
Potential Completion Date 6/17/22
Potential Value $9.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,318.37 Firm Fixed Price delivery order supports the supply of 4554905111 - Nitroglycerin 400 MCG Spray 12GM to the DLA. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,825.44 firm fixed-price delivery order is for the supply of Nitroglycerin 400 MCG Spray, a critical medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
This federal contract award, valued at $1,011.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitroglycerin 400 MCG Spray, a pharmaceutical product, with a performance period extending through April 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) vehicle held by Amerisourcebergen with the DLA, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,628,996 units of Nitroglycerin 400 MCG Spray 4.9 GM and has a ceiling value of $1,078.86. The contract is a Firm Fixed Price arrangement with a period of performance through December 6, 2024. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4.9 gram nitroglycerin 400 mcg spray with a ceiling value of $1,268.74 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 that serves as the...
This federal contract award to Amerisourcebergen Drug Corp is a $1,865.82 firm fixed price delivery order (SPE2DX15D6028|SPE2DX25FWEYC) from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,566,376,613 units of nitroglycerin 12 gram medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,412.00, is for the delivery of nitroglycerin 0.2mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,579.98 fixed-price delivery order is for the supply of 4567741174 - NITROGLYCERIN 12GM 1S, with a completion date of April 1, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
The federal contract award, SPE2DX15D1022|SPE2DX24FVLAT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,936.48 firm fixed-price delivery order is for the supply of 50mg/10mL vials of nitroglycerin, a critical medical commodity used in various therapeutic areas. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of nitroglycerin 12GM 1S medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $2,115.66. The contract has a firm fixed price and an ultimate completion date of July 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FK1K5
    Delivery Order

This federal contract award, with the ID SPE2DB20D3101|SPE2DB22FK1K5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,834.65 Firm Fixed Price delivery order is for the supply of 4557563969 - Nitroglycerin 400 MCG Spray, 12GM. This award was not designated as a set-aside contract.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support military healthcare programs globally. The company also maintains a separate $750,000.00 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.

Generated 2/27/25, 10:21 AM